| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| DIMT1L Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH302326 | 10 ug | ORIGENE TECHNOLOGIES |
| DIO3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN404462 | 1 kit | ORIGENE TECHNOLOGIES |
| DIO1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN405053 | 1 kit | ORIGENE TECHNOLOGIES |
| DIO2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN410376 | 1 kit | ORIGENE TECHNOLOGIES |
| Dio2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504583 | 1 kit | ORIGENE TECHNOLOGIES |
| Dio1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504582 | 1 kit | ORIGENE TECHNOLOGIES |
| Dio3 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504584 | 1 kit | ORIGENE TECHNOLOGIES |
| DIP2A - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN407163 | 1 kit | ORIGENE TECHNOLOGIES |
| Dip2a - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504585 | 1 kit | ORIGENE TECHNOLOGIES |
| DIP2B - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN419412 | 1 kit | ORIGENE TECHNOLOGIES |
| Dip2b - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504586 | 1 kit | ORIGENE TECHNOLOGIES |
| DIP2C - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN409325 | 1 kit | ORIGENE TECHNOLOGIES |
| Dip2c - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504587 | 1 kit | ORIGENE TECHNOLOGIES |
| DIP2 disco-interacting protein 2 homolog C (Drosophila) (DIP2C) from ORIGENE TECHNOLOGIES | LY414870 | 100 ug | ORIGENE TECHNOLOGIES |
| Dipeptidase 2 (DPEP2) from ORIGENE TECHNOLOGIES | LY411681 | 100 ug | ORIGENE TECHNOLOGIES |
| Dipeptidase 1 (renal) (DPEP1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY401402 | 100 ug | ORIGENE TECHNOLOGIES |
| Dipeptidase 1 (renal) (DPEP1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY426893 | 100 ug | ORIGENE TECHNOLOGIES |
| Dipeptidase 3 (DPEP3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY427042 | 100 ug | ORIGENE TECHNOLOGIES |
| Dipeptidyl-peptidase 7 (DPP7) from ORIGENE TECHNOLOGIES | LY402258 | 100 ug | ORIGENE TECHNOLOGIES |
| Dipeptidyl-peptidase 4 (DPP4) from ORIGENE TECHNOLOGIES | LY419637 | 100 ug | ORIGENE TECHNOLOGIES |
| Dipeptidyl-peptidase 9 (DPP9) from ORIGENE TECHNOLOGIES | LY403380 | 100 ug | ORIGENE TECHNOLOGIES |
| Dipeptidyl-peptidase 3 (DPP3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY417120 | 100 ug | ORIGENE TECHNOLOGIES |
| Dipeptidyl-peptidase 10 (DPP10), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412236 | 100 ug | ORIGENE TECHNOLOGIES |
| Dipeptidyl-peptidase 3 (DPP3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY408959 | 100 ug | ORIGENE TECHNOLOGIES |
| Dipeptidyl-peptidase 6 (DPP6), transcript variant 2 from ORIGENE TECHNOLOGIES | LY419638 | 100 ug | ORIGENE TECHNOLOGIES |
| Dipeptidyl-peptidase 8 (DPP8), transcript variant 1 from ORIGENE TECHNOLOGIES | LY403323 | 100 ug | ORIGENE TECHNOLOGIES |
| Dipeptidyl-peptidase 6 (DPP6), transcript variant 3 from ORIGENE TECHNOLOGIES | LY422033 | 100 ug | ORIGENE TECHNOLOGIES |
| Dipeptidyl-peptidase 8 (DPP8), transcript variant 3 from ORIGENE TECHNOLOGIES | LY405157 | 100 ug | ORIGENE TECHNOLOGIES |
| Human Cervix; Adenocarcinoma of cervix, metastatic from ORIGENE TECHNOLOGIES | CS543611 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix; Carcinoma in situ of cervix, squamous cell from ORIGENE TECHNOLOGIES | CS707793 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix; Carcinoma in situ of cervix, squamous cell from ORIGENE TECHNOLOGIES | CS707794 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix; Carcinoma in situ of cervix, squamous cell from ORIGENE TECHNOLOGIES | CS525391 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix; Carcinoma of cervix, adenosquamous from ORIGENE TECHNOLOGIES | CS711423 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix; Carcinoma of cervix, adenosquamous from ORIGENE TECHNOLOGIES | CS711424 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix; Carcinoma of cervix, adenosquamous from ORIGENE TECHNOLOGIES | CS711425 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix; Carcinoma of cervix, small cell, metastatic from ORIGENE TECHNOLOGIES | CS544146 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix; Carcinoma of cervix, adenosquamous from ORIGENE TECHNOLOGIES | CS711426 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix; Carcinoma of cervix, squamous cell from ORIGENE TECHNOLOGIES | CS702897 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix; Carcinoma of cervix, squamous cell from ORIGENE TECHNOLOGIES | CS706046 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix; Carcinoma of cervix, squamous cell from ORIGENE TECHNOLOGIES | CS706568 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix; Carcinoma of cervix, squamous cell from ORIGENE TECHNOLOGIES | CS711495 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix; Carcinoma of cervix, squamous cell from ORIGENE TECHNOLOGIES | CS711496 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix; Carcinoma of cervix, squamous cell from ORIGENE TECHNOLOGIES | CS713866 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix; Carcinoma of cervix, squamous cell from ORIGENE TECHNOLOGIES | CS806612 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix; Carcinoma of cervix, squamous cell from ORIGENE TECHNOLOGIES | CS810299 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix; Carcinoma of cervix, squamous cell from ORIGENE TECHNOLOGIES | CS520602 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix; Carcinoma of cervix, squamous cell from ORIGENE TECHNOLOGIES | CS536981 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix; Carcinoma of cervix, squamous cell, large cell, non-keratinizing from ORIGENE TECHNOLOGIES | CS701434 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix; Carcinoma of cervix, squamous cell, large cell, non-keratinizing from ORIGENE TECHNOLOGIES | CS702100 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Cervix; Carcinoma of cervix, squamous cell, large cell, non-keratinizing from ORIGENE TECHNOLOGIES | CS702101 | 5x5um | ORIGENE TECHNOLOGIES |